|Table of Contents|

Synergistic effect of fecal microbiota transplantation on fluorouracil against colon tumor in mice

Journal Of Modern Oncology[ISSN:1672-4992/CN:61-1415/R]

Issue:
2024 17
Page:
3213-3219
Research Field:
Publishing date:

Info

Title:
Synergistic effect of fecal microbiota transplantation on fluorouracil against colon tumor in mice
Author(s):
YANG Qiuyu1SUN Yuhang2TAN Mengtian1BAI Jing2LI Lei2YANG Yong2WU Fang2LI He1FU Zexian1
1.Hebei University of Engineering,Hebei Handan 056000,China;2.Affiliated Hospital of Hebei University of Engineering,Hebei Handan 056038,China.
Keywords:
fecal microbiota transplantationtumor immunizationtumor-bearing micesubcutaneous tumor model
PACS:
R735.3
DOI:
10.3969/j.issn.1672-4992.2024.17.008
Abstract:
Objective:To observe the synergistic effect of fecal microbiota transplantation on the inhibition of graft tumor growth by fluorouracil in MC38 mouse colon cancer cells loaded mice.Methods:21 female C57BL/6N mice were selected as study subjects and divided into blank group,control group and experimental group.MC38 mouse colon cancer cells were used to inoculate the mice subcutaneously on the back of the right forelimb to construct a colon cancer hormonal tumor model.The blank group was treated without any treatment,and its feces were taken to make the intervention bacterial solution,and the experimental and control groups were given 0.1 mL bacterial solution/saline gavage once every two days since the grouping until the end of the experiment.On the 6th day after tumor formation,fluorouracil was injected intraperitoneally for 5 consecutive days at a dose of 65 mg/kg,and the experimental animals were executed after 3 days to calculate the tumor volume and tumor suppression rate.The colorectal tissues were observed by HE staining.Serum levels of interleukin-6(IL-6) and tumor necrosis factor alpha(TNF-α) were detected by enzyme-linked immunosorbent assay(ELISA),and intestinal flora was detected and analyzed by 16S sequencing.Results:Compared with the blank group,the body weight of the model mice in both the experimental and control groups was significantly reduced(P<0.05),but no significant difference in body weight change was observed between the control and experimental groups(P>0.05).The average volume of the control group's loaded tumors was larger than the average volume of the experimental group's loaded tumors(P<0.05).Compared with the control group,more crypt cells with more intact villi were seen microscopically in the histopathologic histological sections of colorectal tissue in the experimental group.The serum level of IL-6 in the experimental group was higher than that in the control group and the blank group(P<0.05).The serum level of TNF-α in the experimental group and the control group was significantly higher compared with that in the blank group(P<0.05),but the difference between the experimental group and the control group was not statistically significant(P<0.05).The 16S sequencing results suggested that,after the intervention of autologous bacterial transplantation,the intestinal bacterial flora of the experimental group was closer to that of the blank group,and the bacterial abundance in the control group was the lowest,but no significant difference was seen among the three groups(P<0.05).Further analysis of the differences in the flora of the three groups revealed that at the genus level,Mar-Odoribacter and Tan-Parabacteroide in the experimental group and Ent-Escherichia-Shigella in the control group were more enriched compared with the blank group.Conclusion:Up-regulation of Mar-Odoribacter and Tan-Parabacteroide bacteria and down-regulation of Ent-Escherichia-Shigella bacteria after fecal microbiota transplantation protects the intestinal mucosa,improves the metabolism of the organism,activates the immune system of the organism,and promotes the expression of IL-6 and TNF-α cytokines,which enhances the anti-tumor immune ability,and has an effect on the fluorouracil synergistically inhibits the proliferation of transplanted tumors in MC38 hormonal mice.

References:

[1]BRAY F,LAVERSANNE M,SUNG H,et al.Global cancer statistics 2022:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J].CA Cancer J Clin,2024,74(3):229-263.
[2]AN J,SEOK H,HA EM.GABA-producing Lactobacillus plantarum inhibits metastatic properties and induces apoptosis of 5-FU-resistant colorectal cancer cells via GABA(B) receptor signaling[J].J Microbiol,2021,59(2):202-216.
[3]BOLEIJ A,HECHENBLEIKNER EM,GOODWIN AC,et al.The Bacteroides fragilis toxin gene is prevalent in the colon mucosa of colorectal cancer patients[J].Clin Infect Dis,2015,60(2):208-215.
[4]WANG JW,KUO CH,KUO FC,et al.Fecal microbiota transplantation:Review and update[J].J Formos Med Assoc,2019,118(Suppl 1):S23-S31.
[5]WEN X,WANG HG,ZHANG MN,et al.Fecal microbiota transplantation ameliorates experimental colitis via gut microbiota and T-cell modulation[J].World J Gastroenterol,2021,27(21):2834-2849.
[6]桂冠,易健,张善金,等.粪菌移植疗法治疗晚期结直肠癌FOLFIRI化疗方案相关难治性腹泻的效果观察[J].中国医学创新,2021,18(30):10-14. GUI G,YI J,ZHANG SJ,et al.Effectiveness of fecal bacteria transplantation therapy in treating refractory diarrhea associated with FOLFIRI chemotherapy regimen in advanced colorectal cancer[J].China Medical Innovation,2021,18(30):10-14.
[7]孟敏,刘凯,杨雪,等.粪便菌群移植治疗难辨梭状芽孢杆菌感染有效性及安全性的系统评价再评价[J].中国循证医学杂志,2017,17(11):1318-1324. MENG M,LIU K,YANG X,et al.Re-evaluation of systematic evaluation of the effectiveness and safety of fecal flora transplantation for Clostridium difficile infection[J].Chinese Journal of Evidence-Based Medicine,2017,17(11):1318-1324.
[8]ZAINAH H,HASSAN M,SHIEKH-SROUJIEH L,et al.Intestinal microbiota transplantation,a simple and effective treatment for severe and refractory clostridium difficile infection[J].Digestive Diseases and Sciences,2014,60(1):181-185.
[9]SOUGIANNIS AT,VANDERVEEN BN,ENOS RT,et al.Impact of 5 fluorouracil chemotherapy on gut inflammation,functional parameters,and gut microbiota[J].Brain Behav Immun,2019,80:44-55.
[10]CHEN ML,SUNDRUD MS.Xenobiotic and endobiotic handling by the mucosal immune system[J].Curr Opin Gastroenterol,2018,34(6):404-412.
[11]董拓周,公雪,李大林.菌群移植联合PD-L1抑制剂及化疗治疗三阴性乳腺癌的展望[J].现代肿瘤医学,2023,31(6):1177-1180. DONG TZ,GONG X,LI DL.Prospect of fecal microbiota transplantation combined with PD-L1 inhibitors and chemotherapy in the treatment of triple-negative breast cancer[J].Modern Oncology,2023,31(6):1177-1180.
[12]OTA K,TAKEUCHI T,KOJIMA Y,et al.Fluoropyrimidine-induced intestinal mucosal injury is associated with the severity of chemotherapy-related diarrhea[J].Scand J Gastroenterol,2019,54(2):227-232.
[13]CHENG H,ZHAO L,JU Z,et al.Effects of 10.6-μm laser moxibustion and electroacupuncture at ST36 in a 5-FU-induced diarrhea rat model[J].Support Care Cancer,2021,29(5):2561-2569.
[14]董文钦,朱耀东,李平,等.亮菌口服液对5-FU化疗后小鼠肠黏膜屏障及肠道菌群移位的影响[J].安徽医科大学学报,2019,54(7):1066-1071. DONG WQ,ZHU YD,LI P,et al.Effects of Leuconostoc oral solution on intestinal mucosal barrier and intestinal flora shift in mice after 5-FU chemotherapy[J].Journal of Anhui Medical University,2019,54(7):1066-1071.
[15]SI X,BI J,CHEN Q,et al.Effect of blueberry anthocyanin-rich extracts on peripheral and hippocampal antioxidant defensiveness:The analysis of the serum fatty acid species and gut microbiota profile[J].J Agric Food Chem,2021,69(12):3658-3666.
[16]HIRANO T.IL-6 in inflammation,autoimmunity and cancer[J].Int Immunol,2021,33(3):127-148.
[17]FOEGEDING NJ,BYNDLOSS MX.Taking on cancer[J].Cell Host Microbe,2021,29(6):851-853.
[18]袁静,缪洪明.肿瘤相关巨噬细胞MGLL缺失促进免疫抑制和结直肠癌细胞腹腔种植转移[J].陆军军医大学学报,2023,45(6):530-538. YUAN J,MIU HM.MGLL deficiency in tumor-associated macrophages promotes immunosuppression and metastasis of colorectal cancer cells by abdominal implantation[J].Journal of Army Medical University,2023,45(6):530-538.
[19]CHEN D,WU J,JIN D,et al.Fecal microbiota transplantation in cancer management:Current status and perspectives[J].Int J Cancer,2019,145(8):2021-2031.
[20]金梁,李慧杰,王信,等.肠道菌群与结直肠癌发生及中医药调节作用的研究现状[J].现代肿瘤医学,2022,30(18):3412-3415. JIN L,LI HJ,WANG X,et al.Research status of intestinal flora and colorectal cancer occurrence and regulation of traditional Chinese medicine[J].Modern Oncology,2022,30(18):3412-3415.
[21]HAN S,PAN Y,YANG X,et al.Intestinal microorganisms involved in colorectal cancer complicated with dyslipidosis[J].Cancer Biol Ther,2019,20(1):81-89.
[22]RIQUELME E,ZHANG Y,ZHANG L,et al.Tumor microbiome diversity and composition influence pancreatic cancer outcomes[J].Cell,2019,178(4):795-806.

Memo

Memo:
河北省教育厅科学研究项目(编号:ZD2022039)
Last Update: 2024-07-31